Inhibition of caspase 3 mediated survival signaling, such as PGE2 or components of the Wnt signaling pathway, may represent a novel approach to reduce mucinous tumor repopulation following chemotherapy. The gene discussed is CASP3; the disease is mucinous neoplasm.